Target intelligence / Profile preview

Influenza A virus polymerase basic protein 1 (PB1)

Target
PB1
Molecular classification
Enzyme, RNA-directed RNA polymerase, Viral protein
01

Overview

Influenza A virus polymerase basic protein 1 (PB1) is the catalytic core of the heterotrimeric RNA-dependent RNA polymerase (RdRp) complex, which is essential for the replication and transcription of the viral genome (UniProt: P03433). Unlike the surface glycoproteins hemagglutinin and neuraminidase, which undergo frequent antigenic drift, PB1 is highly conserved across various influenza A subtypes, including H1N1, H3N2, and H5N1 (Assarsson et al., J Virol, 2008). This conservation makes PB1 a primary target for the development of universal influenza vaccines that utilize T-cell epitopes to provide broad-spectrum immunity. T-cells recognizing these conserved epitopes can identify and destroy infected cells across different viral strains, potentially mitigating the impact of seasonal shifts and future pandemics (Gras et al., J Immunol, 2010). In addition to vaccine development, PB1 is a target for small-molecule antivirals such as Favipiravir, which acts as a nucleotide analogue that is incorporated into the viral RNA, leading to the termination of RNA synthesis or lethal mutagenesis (Furuta et al., Antiviral Res, 2013). Therapeutic strategies focusing on PB1 conserved T-cell epitopes aim to provide long-lasting, cross-protective cellular immunity that complements the strain-specific humoral immunity provided by traditional vaccines. However, the effectiveness of such T-cell-based therapies is often dependent on the host's Human Leukocyte Antigen (HLA) profile, which determines the presentation of these epitopes to the immune system (Hillaire et al., J Virol, 2013).

Other names
RNA-directed RNA polymerase catalytic subunitPolymerase basic protein 1PB1 subunitInfluenza A virus PB1PB1 protein
02

Mechanism of action

Inhibition of viral RNA-dependent RNA polymerase activity through chain termination or lethal mutagenesis, or induction of cross-reactive CD8+ and CD4+ T-cell mediated immunity against conserved internal viral peptides to clear infected cells (Furuta et al., Antiviral Res, 2013; Atsmon et al., Sci Rep, 2012).

03

Biological functions

Viral genome replicationRNA transcriptionRNA synthesisImmune response induction
04

Disease associations

Influenza A infectionRespiratory tract infectionPandemic influenza
05

Safety considerations

Potential for viral resistance mutationsRisk of immunopathology or cytokine dysregulationHLA-restriction limiting population-wide efficacyPotential for cross-reactivity with host proteins
06

Interacting drugs

Favipiravir

4 more in the full profile.

07

Biomarkers

PB1-specific CD8+ T-cell frequencyInterferon-gamma (IFN-γ) secretion levelsViral load reductionGranyzme B production

Beyond the preview

Go deeper on Influenza A virus polymerase basic protein 1 (PB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus polymerase basic protein 1 (PB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call